Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL4167360

IDH305
🧪 Phase II
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
🧪 Phase II
Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)F)n2)ncc1-c1ccnc(C(F)(F)F)c1

Basic Information

ChEMBL ID CHEMBL4167360
Name IDH305
Phase Phase II
Structure Type MOL
InChI Key DCGDPJCUIKLTDU-QWQRMKEZSA-N

Known Names

Idh305
1
Targets
2
Activities
1
Assay Types
1
PK Parameters
2
Publications
1
Known Names
3
Indications
2
Mechanisms

Molecular Properties

490.5
MW (Da)
5.12
ALogP
7
HBA
1
HBD
93.1
PSA (Ų)
0.48
QED
1
Ro5 Violations
6
Rot. Bonds

Drug Information

Molecule Type Small molecule
Chirality Unknown

Extended Properties

Molecular Formula C23H22F4N6O2
MW 490.46
Aromatic Rings 3
Heavy Atoms 35
NP-Likeness -0.79

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Isocitrate dehydrogenase [NADP] cytoplasmic inhibitor INHIBITOR Isocitrate dehydrogenase [NADP] cytoplasmic
Isocitrate dehydrogenase [NADP] cytoplasmic inhibitor INHIBITOR Isocitrate dehydrogenase [NADP] cytoplasmic

Indications

Paraganglioma Leukemia, Myeloid, Acute Neoplasms

Activity Summary

IC50 2 meas. best 7.14

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Isocitrate dehydrogenase [NADP] cytoplasmic
CHEMBL2007625
IC50 7.14 6.82 73.0 2

Pharmacokinetic Data

Parameter Value Units Species
CL 157.0 mL.min-1.g-1 Rattus norvegicus

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
29057061 10.1021/acsmedchemlett.7b00342 Isocitrate dehydrogenase [NADP] cytoplasmic 2
29057061 10.1021/acsmedchemlett.7b00342 ADMET 1

Data from ChEMBL 36 via Core Engine